What is the Janssen carepath?
Janssen CarePath helps verify insurance coverage for your patients, provides reimbursement information, helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on STELARA ® . What Janssen CarePath can do for you on behalf of your patients
How can I get additional support with Stelara®?
Janssen CarePath provides the additional support you may need to help you get started with STELARA ® treatment, once you and your doctor have decided that STELARA ® is right for you. A personally assigned Janssen CarePath Care Coordinator will work closely with you and your doctor to provide the support you need.
Does Janssen provide reimbursement for prescription drugs?
This information is provided for informational purposes only and represents no statement, promise, or guarantee by Janssen concerning levels of reimbursement, payment, or charge. The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free.
What is the savings program for Stelara®?
The Savings Program for STELARA ® provides a rebate when used with medical/primary insurance and provides instant savings when used with pharmacy/prescription insurance. See full eligibility requirements. Get your eligible patients started today:
Does Janssen Pharmaceuticals have a patient assistance program?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
What can I use my Janssen CarePath card for?
The Janssen CarePath Savings Program is designed to help lower eligible patients' out-of-pocket medication costs for their Janssen medication. Eligible patients using commercial or private insurance to pay for their Janssen medication will receive savings off their deductible, co-pay, and co-insurance medication costs.
How much does STELARA cost per month?
Prices will also vary by retailer. As a guide, you'll pay around $26,500 for 1 ml of Stelara 90 mg/mL subcutaneous solution. With NiceRx you'll always pay a flat monthly fee of $49.
How much does one syringe of STELARA cost?
The cost for Stelara subcutaneous solution (45 mg/0.5 mL) is around $13,434 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Does Janssen CarePath work with Medicare?
If you use commercial or private health insurance, Janssen CarePath Savings Program may help you save on your out-of-pocket costs. Patients using Medicare, Medicaid, or any other federally funded programs to pay for their Janssen medication are not eligible to participate.
Does Janssen CarePath count towards deductible?
Janssen CarePath Savings Program can help eligible commercially-insured patients save on out-of-pocket costs for their Janssen medication. Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible.
How long can you stay on STELARA?
It is important that you tell your doctor about any new symptoms you notice. This will help prevent any potential complications or catch them at an early stage. Your IBD team should give you a check-up to see whether you should continue having Stelara after 12 months of treatment.
Is STELARA on the sad list?
At the outset of the COVID-19 public health emergency (PHE), several MACs added ustekinumab (Stelara) to the SAD list (which will take effect 45-days after the PHE ends). Ustekinumab has a number of approved clinical indications, including plaque psoriasis, psoriatic arthritis and Crohn's disease.
Is STELARA better than Humira?
Though Stelara measured up to AbbVie's leading med, it failed to top Humira in any efficacy measure in the study, called Seavue. At the 52-week mark, 64.9% of Stelara patients had hit clinical remission, compared with 61% of patients taking Humira—a numerical difference, but not a statistically significant one.
Is there a generic version of STELARA?
There are currently no generic alternatives to Stelara.
Does STELARA weaken your immune system?
STELARA® may decrease the activity of your immune system and increase your risk for certain types of cancer.
What happens if you stop taking STELARA?
Are there any side effects from stopping Stelara treatment? No, stopping Stelara use shouldn't cause side effects. However, if you stop taking Stelara, the condition you're taking it to treat may come back or get worse.
Does Medicare Part B pay for STELARA?
Since 2016, total Medicare Part B payments to physicians for Stelara-an expensive drug used to treat certain autoimmune diseases that is often self-injected by patients in their home-have increased substantially.
Is there a generic version of STELARA?
This medication may also be recommended for the treatment of moderate to severe Crohn's disease. The generic version of Stelara is ustekinumab.
How much is STELARA in the US?
Stelara injection: Just like the spray version of this medicine, the Stelara injection is used to manage various psoriatic conditions in adult patients. The retail price of a supply of 0.5 milliliters of Stelara is around $10,770.
Does STELARA weaken your immune system?
STELARA® may decrease the activity of your immune system and increase your risk for certain types of cancer.
What is Janssen committed to?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
What is JJPAF in medicine?
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is JJPAF?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson. JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is PPA in healthcare?
The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free. PPA offers a single point of access to more than 475 public and private programs, including nearly 200 offered by pharmaceutical companies.
Can you get a lung infection with stalara?
Cases of lung inflammation have happened in some people who receive STELARA ® and may be serious. These lung problems may need to be treated in a hospital. Tell your doctor right away if you develop shortness of breath or a cough that doesn’t go away during treatment with STELARA ® .
Does STELARA cause death?
People who have a genetic problem where the body does not make any of the proteins interleukin 12 (IL‐12) and interleukin 23 (IL‐23) are at a higher risk for certain serious infections that can spread throughout the body and cause death. People who take STELARA ® may also be more likely to get these infections.
What is the phone number for Janssen Carepath?
If you have any questions, please call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728) , Monday-Friday, 8:00 AM to 8:00 PM ET. Multilingual phone support is available.
What is a stalera?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
Can you administer stalara to TB patients?
Evaluate patients for TB prior to initiating treatment with STELARA ®. Do not administer STELARA ® to patients with active tuberculosis infection . Initiate treatment of latent TB before administering STELARA ®. Closely monitor patients receiving STELARA ® for signs and symptoms of active TB during and after treatment.
Is PRES a reversible encephalopathy?
Two cases of posterior reversible encephalopathy syndrome (PRES), also known as Reversible Posterior Leukoencephalopathy Syndrome (RPLS), were reported in clinical trials. Cases have also been reported in postmarketing experience in patients with psoriasis, psoriatic arthritis and Crohn’s disease. Clinical presentation included headaches, seizures, confusion, visual disturbances, and imaging changes consistent with PRES a few days to several months after ustekinumab initiation. A few cases reported latency of a year or longer. Patients recovered with supportive care following withdrawal of ustekinumab.
Can you discontinue Stelara?
Hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with STELARA ®. If an anaphylactic or other clinically significant hypersensitivity reaction occurs , institute appropriate therapy and discontinue STELARA ® .
Can you take stelara with methotrexate?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with active psoriatic arthritis. STELARA ® can be used alone or in combination with methotrexate (MTX).
Can you get a lung infection with stalara?
Cases of lung inflammation have happened in some people who receive STELARA ® and may be serious. These lung problems may need to be treated in a hospital. Tell your doctor right away if you develop shortness of breath or a cough that doesn’t go away during treatment with STELARA ® .
Does STELARA cause death?
People who have a genetic problem where the body does not make any of the proteins interleukin 12 (IL‐12) and interleukin 23 (IL‐23) are at a higher risk for certain serious infections that can spread throughout the body and cause death. People who take STELARA ® may also be more likely to get these infections.
What is JJPAF in healthcare?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. To see if they might qualify for assistance, please have your patient contact a JJPAF program specialist at 800-652-6227 (Monday–Friday, 9:00 AM to 6:00 PM ET) or visit the foundation website at JJPAF.org .
What is a stalera?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
Can you administer stalara to TB patients?
Evaluate patients for TB prior to initiating treatment with STELARA ®. Do not administer STELARA ® to patients with active tuberculosis infection . Initiate treatment of latent TB before administering STELARA ®. Closely monitor patients receiving STELARA ® for signs and symptoms of active TB during and after treatment.
Is PRES a reversible encephalopathy?
Two cases of posterior reversible encephalopathy syndrome (PRES), also known as Reversible Posterior Leukoencephalopathy Syndrome (RPLS), were reported in clinical trials. Cases have also been reported in postmarketing experience in patients with psoriasis, psoriatic arthritis and Crohn’s disease. Clinical presentation included headaches, seizures, confusion, visual disturbances, and imaging changes consistent with PRES a few days to several months after ustekinumab initiation. A few cases reported latency of a year or longer. Patients recovered with supportive care following withdrawal of ustekinumab.
Can you discontinue Stelara?
Hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with STELARA ®. If an anaphylactic or other clinically significant hypersensitivity reaction occurs , institute appropriate therapy and discontinue STELARA ® .
Can you submit a completed enrollment form to Janssen CarePath?
Or patients can submit a completed enrollment form to Janssen CarePath .
Can you take stelara with methotrexate?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with active psoriatic arthritis. STELARA ® can be used alone or in combination with methotrexate (MTX).
What is a stalera?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease.
Can you discontinue Stelara?
Hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with STELARA ®. If an anaphylactic or other clinically significant hypersensitivity reaction occurs , institute appropriate therapy and discontinue STELARA ® .
Can you take stelara with methotrexate?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with active psoriatic arthritis. STELARA ® can be used alone or in combination with methotrexate (MTX).
Can you administer stalara to TB patients?
Evaluate patients for TB prior to initiating treatment with STELARA ®. Do not administer STELARA ® to patients with active tuberculosis infection . Initiate treatment of latent TB before administering STELARA ®. Closely monitor patients receiving STELARA ® for signs and symptoms of active TB during and after treatment.
Is PRES a reversible encephalopathy?
Two cases of posterior reversible encephalopathy syndrome (PRES), also known as Reversible Posterior Leukoencephalopathy Syndrome (RPLS), were reported in clinical trials. Cases have also been reported in postmarketing experience in patients with psoriasis, psoriatic arthritis and Crohn’s disease. Clinical presentation included headaches, seizures, confusion, visual disturbances, and imaging changes consistent with PRES a few days to several months after ustekinumab initiation. A few cases reported latency of a year or longer. Patients recovered with supportive care following withdrawal of ustekinumab.
Is stalara contraindicated?
STELARA ® (ustekinumab) is contraindicated in patients with clinically significant hypersensitivity to ustekinumab or to any of the excipients.
What is a stalera?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease.
Does Medicare cover end stage renal disease?
Individuals diagnosed with end-stage renal disease (ESRD) While Medicare covers many healthcare needs, it may not cover all of the patient's healthcare costs. The patient may have to pay a monthly premium for Medicare and then pay a co-insurance and a deductible for many services.
Can you administer stalara to TB patients?
Evaluate patients for TB prior to initiating treatment with STELARA ®. Do not administer STELARA ® to patients with active tuberculosis infection . Initiate treatment of latent TB before administering STELARA ®. Closely monitor patients receiving STELARA ® for signs and symptoms of active TB during and after treatment.
Is PRES a reversible encephalopathy?
Two cases of posterior reversible encephalopathy syndrome (PRES), also known as Reversible Posterior Leukoencephalopathy Syndrome (RPLS), were reported in clinical trials. Cases have also been reported in postmarketing experience in patients with psoriasis, psoriatic arthritis and Crohn’s disease. Clinical presentation included headaches, seizures, confusion, visual disturbances, and imaging changes consistent with PRES a few days to several months after ustekinumab initiation. A few cases reported latency of a year or longer. Patients recovered with supportive care following withdrawal of ustekinumab.
Can you discontinue Stelara?
Hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with STELARA ®. If an anaphylactic or other clinically significant hypersensitivity reaction occurs , institute appropriate therapy and discontinue STELARA ® .
Is stalara contraindicated?
STELARA ® (ustekinumab) is contraindicated in patients with clinically significant hypersensitivity to ustekinumab or to any of the excipients.
What is The Patient Assistance Program?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
Program Update
Patients may now choose the option of electronic income verification. Instead of submitting a copy of their Federal tax return, they can simply check a box on the updated application form.
